Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone
Author(s) -
O. Hamdine,
Marinus J.C. Eijkemans,
E. Lentjes,
Helen L. Torrance,
N.S. Macklon,
Bart C.J.M. Fauser,
Frank J. Broekmans
Publication year - 2014
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deu266
Subject(s) - anti müllerian hormone , medicine , hormone antagonist , antagonist , ovarian reserve , gynecology , ovulation induction , agonist , in vitro fertilisation , hormone , pregnancy , andrology , infertility , biology , ovulation , receptor , genetics
What is the clinical value of anti-Müllerian hormone (AMH) for the prediction of high or low ovarian response in controlled ovarian stimulation for IVF using GnRH antagonist treatment?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom